Unit 8: Musculoskeletal Flashcards

1
Q

Joints commonly affected in osteoarthritis

A

Knees, hips, cervical/lumbar spine, distal interphalangeal joints, carpometacarpal joint

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathophys of osteoarthritis

A

Deterioration of articular cartilage, which usually decreases joint friction during movement; decrease in proteoglycans in extracellular matrix; underlying subchondral bone responds by remodeling; osteophytes form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pain of osteoarthritis

A

Intermittent, mild; exacerbated by joint movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

First line pharmacotherapy for analgesia of osteoarthritis

A

Acetaminophen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Second line therapy for osteoarthritis

A

NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-acetylated salicylates

A

Diflunisal

Beneficial in patients with osteoarthritis who are sensitive to GI irritation caused by aspirin or other NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Topical agents for osteoarthritis

A

Capsalcin: decreases substance P
Dicloferiac: topical NSAID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Corticosteroids for osteoarthritis

A

Indicated if 1-2 joints are involved and has not responded to 1st or 2nd line treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gout

A

Inflammatory condition that results from mono sodium urate crystals precipitating in synovial fluid between joints due to hyperuricemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Most common cause of gout

A

Underexcretion of uric acid through insufficient renal clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First line therapy for chronic gout treatment

A

Xanthine oxidase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Xanthine oxidase inhibitors

A

Allopurinol and Febuxostat
Decrease uric acid levels by selectively inhibiting xanthine oxidase which is primarily responsible for converting xanthine to uric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Probenecid

A

Increase excretion of serum uric acid by inhibiting reabsorption of uric acid at proximal tubule
Used if at least one xanthine oxidase inhibitor is contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of acute gout

A

Rest joint, apply ice, short course of NSAIDs, steroids or colchicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Colchicine

A

Inhibits activation, degranulation and migration of neutrophils to area of gout attack
Take within 24 hours of attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rheumatoid arthritis

A

Synovial membrane proliferation followed by erosion of the subarticular cartilage and subchondral bone
Morning stiffness in involved joints for 1 hour and subsides with activity

17
Q

NSAIDs for RA

A

Continue from initial diagnosis until initiation of DMARD

18
Q

Corticosteroids for RA

A

Low dose steroids (prednisone) beneficial for those starting DMARDs
Higher doses beneficial in acute flares to gain control of inflammation and pain

19
Q

DMARDs

A

Disease modifying anti rheumatic drugs
Methotrexate, sulfasalazine, hydroxychloroquine, Leflunomide
Should be initiated within 3 months of onset of symptoms

20
Q

Methotrexate

A

Folic acid antagonist
Affects leukocyte suppresison; decreases inflammation
CI in pregnancy and BF

21
Q

Biologic disease modifying antirheumatic drugs

A

Tumor necrosis factor inhibitors

Etanercept, infliximab, adalimumab, golimumab, certolizumab

22
Q

First line therapy for low disease activity

A

Monotherapy DMARD

23
Q

First line therapy for moderate disease activity with poor prognostic factors

A

Combination of DMARDs

24
Q

First line therapy for high disease activity without poor prognostic factors

A

DMARD monotherapy or combo methotrexate and hydroxychloroquine

25
Q

First line therapy for high disease activity with poor prognostic factors

A

Either combo DMARD or anti TNF with or without methotrexate